Connect with us

Hi, what are you looking for?

[stock_market_widget type="ticker-quotes" template="chart" color="#5679FF" assets="MSFT,AAPL,NFLX,GOOG,TSLA,NFLX,AMZN" animation="true" display_currency_symbol="true" api="yf" speed="50" direction="left" pause="true"]

Top Stories

Health-insurance stocks drop after Medicare Advantage proposes lower rates for 2024

A proposal for lower-than-expected Medicare Advantage rates in 2024 has sent shares of publicly traded health insurers falling. UnitedHealth Group Inc.’s UNH, -5.26% stock fell 1.2% in trading on Thursday, shares of Elevance Health Inc. ELV, -4.19% were down 3.3% and Molina Healthcare Inc.’s MOH, -1.76% stock tumbled 1.6%. Centene Corp.’s CNC, -3.11% stock was

health-insurance-stocks-drop-after-medicare-advantage-proposes-lower-rates-for-2024

A proposal for lower-than-expected Medicare Advantage rates in 2024 has sent shares of publicly traded health insurers falling.

UnitedHealth Group Inc.’s UNH, -5.26% stock fell 1.2% in trading on Thursday, shares of Elevance Health Inc. ELV, -4.19% were down 3.3% and Molina Healthcare Inc.’s MOH, -1.76% stock tumbled 1.6%. Centene Corp.’s CNC, -3.11% stock was down 3.0%, shares of Cigna Corp. CI, -3.41% dropped 2.2% and Humana Inc.’s HUM, -4.39% stock declined 3.3%.

The Centers for Medicare and Medicaid Services on Wednesday proposed new Medicare Advantage rates for 2024, including a core rate increase of 2.09%. Rates have averaged 3.3% over the past five years, according to Oppenheimer analyst Michael Wiederhorn. A final decision is expected April 3.

“While the result is disappointing, the industry has been the beneficiary of some healthy increases in recent years,” Wiederhorn told investors. “Additionally, we note that over the last five years, the final rule has come in 1.0% better than the proposal, on average.”

Mizuho Securities analysts noted that the rate is lower than expected but still view the proposal as positive for managed-care companies.

“While the lower rate [year over year] could impact benefits offered to Medicare beneficiaries, we believe it will allow the industry to continue to grow in the high-single digits,” Mizuho analyst Ann Hynes wrote in an investor note. “While the Biden administration has discussed potential reforms to Medicare Advantage, we do not believe the Biden administration will make major structural changes to the MA program this year.”

The Health Care Select Sector SPDR ETF XLV, -0.91% was also down about 1% in trading on Thursday morning.

Advertisement. Scroll to continue reading.

You May Also Like

Stocks

SAN FRANCISCO (MarketWatch) — Among the companies whose shares are expected to see active trade in Thursday’s session are BlackBerry Ltd., Oracle Corp., and...

Mining

NAL spodumene concentrate production remains targeted for H1 2023 with revenue potential in Q3 2023. Credit: Piedmont Piedmont Lithium (Nasdaq: PLL; ASX: PLL) announced...

Tech

This holiday season, consider giving the gift of security with an ad blocker. That’s the takeaway message from an unlikely source — the FBI...

Top Stories

There have been major developments out of Japan this week. The Bank of Japan surprised the market by widening its yield curve target by...

Advertisement